Omeros (OMER) Change in Receivables (2010 - 2026)
Omeros (OMER) reported Change in Receivables of $1.1 million for Q1 2026, up 268.17% on a YoY basis from $302845.1 in Q1 2025, and down 72.19% sequentially from $4.0 million in Q4 2025.
Omeros (OMER) Change in Receivables (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Change in Receivables data on file, last reported at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 268.17% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (up 975.62% YoY), and the FY2025 full-year result was $3.2 million, up 990.2% from the prior year.
- Change in Receivables fell to $1.1 million in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $199.4 million in Q4 2022 to a low of -$203.2 million in Q1 2023.
- A 5-year average of -$1.5 million and a median of -$454000.0 in 2024 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables surged 4583.27% in 2022 and tumbled 827.8% in 2023, its largest moves.
- Tracing OMER's Change in Receivables over 5 years: stood at $199.4 million in 2022, then slumped by 99.39% to $1.2 million in 2023, then advanced by 17.65% to $1.4 million in 2024, then jumped by 179.76% to $4.0 million in 2025, then sank by 72.19% to $1.1 million in 2026.
- Business Quant data shows OMER's Change in Receivables at $1.1 million in Q1 2026, $4.0 million in Q4 2025, and $632000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 632,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | 438,000.00 |
| Jun 30, 2024 | 438,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |